Stay updated on HZN-825 in Systemic Sclerosis: Clinical Trial
Sign up to get notified when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.

Latest updates to the HZN-825 in Systemic Sclerosis: Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision label updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a versioning update to the page rather than a substantive change in its content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe displayed revision/version indicator on the page has been updated from **v3.5.2** to **v3.5.3**, reflecting a non-content site change.SummaryDifference0.1%

- Check30 days agoChange DetectedUpdated the site revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedResults for the trial were posted, detailing Week 52 outcomes for FVC% predicted, mRSS, CRISS 25, HAQ‑DI, CGA, PTGA, SSPRO‑18, and TEAEs; the page now includes linked documents such as the Study Protocol and Statistical Analysis Plan.SummaryDifference4%

- Check59 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision label on the page updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to HZN-825 in Systemic Sclerosis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.